LifeStance Health Group, Inc. (NASDAQ: LFST) recently released its quarterly report for the period ending March 31, 2025, showcasing a moderate revenue growth while addressing a few operational challenges.
Positive Aspects:
Total Revenue: Increased by 11% to $332.97 million from $300.44 million ...